Diagonal Bio AB (DIABIO) — Financial Flexibility Index
Diagonal Bio AB (DIABIO) has a Financial Flexibility Index of -1.07x as of September 2025. Free cash flow of Skr-2.27 Million (operating CF Skr-2.27 Million minus capex Skr0.00) represents -1% of total liabilities (Skr2.13 Million). Also explore Diagonal Bio AB (DIABIO) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Diagonal Bio AB Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Diagonal Bio AB across 5 annual periods. See net asset quality index of Diagonal Bio AB to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Diagonal Bio AB (2020–2024)
Year-by-year free cash flow to debt coverage for Diagonal Bio AB. For the full company profile including market capitalisation, see Diagonal Bio AB (DIABIO) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.77x | Skr-12.10 Million | Skr-13.77 Million | Skr2.54 Million | ▼ -3412.7% |
| 2023 | -0.14x | Skr-985.00K | Skr-5.23 Million | Skr7.26 Million | ▲ +96.5% |
| 2022 | -3.90x | Skr-10.82 Million | Skr-15.77 Million | Skr2.78 Million | ▼ -255.5% |
| 2021 | -1.10x | Skr-2.35 Million | Skr-10.94 Million | Skr2.14 Million | ▼ -622.0% |
| 2020 | 0.21x | Skr226.67K | Skr226.67K | Skr1.08 Million | — |